Seroprevalence to Influenza A(H1N1) 2009 Virus—Where Are We?

Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May – 3 June 2009

(2017) E S McBryde et al.   Eurosurveillance

Pandemic H1N1 influenza lessons from the southern hemisphere

(2017) M G Baker et al.   Eurosurveillance

Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October – December 2009

(2017) J McVernon et al.   Eurosurveillance

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza AH1N1 2009

(2014) P Hardelid et al.   HEALTH TECHNOLOGY ASSESSMENT

Recipients of Vaccine against the 1976 “Swine Flu” Have Enhanced Neutralization Responses to the 2009 Novel H1N1 Influenza Virus

(2010) Jonathan A. McCullers et al.   CLINICAL INFECTIOUS DISEASES

The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong

(2010) Joseph T. Wu et al.   CLINICAL INFECTIOUS DISEASES

Moderate pandemic, not many dead—learning the right lessons in Europe from the 2009 pandemic

(2010) Angus Nicoll et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Original Article: Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses

(2010) Venkata R. S. K. Duvvuri et al.   Influenza and Other Respiratory Viruses

2009 Influenza A(H1N1) Seroconversion Rates and Risk Factors Among Distinct Adult Cohorts in Singapore

(2010) Mark I. C. Chen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Seroprevalence of Antibodies to Pandemic (H1N1) 2009 Influenza Virus Among Hospital Staff in a Medical Center in Taiwan

(2010) Yu-Jiun Chan et al.   Journal of the Chinese Medical Association

Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-React against 2009 Pandemic H1N1 Influenza Virus

(2010) W. Tu et al.   JOURNAL OF VIROLOGY

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

(2010) Elizabeth Miller et al.   LANCET

Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

(2010) Regina Allwinn et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

(2010) Ana Clara Monsalvo et al.   NATURE MEDICINE

Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households

(2010) Benjamin J. Cowling et al.   NEW ENGLAND JOURNAL OF MEDICINE

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA

(2010) Shanta M. Zimmer et al.   PLoS One

Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter

(2010) Gwendolyn L. Gilbert et al.   PLoS One

Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic

(2010) Don Bandaranayake et al.   PLoS One

Cross-reactive CD8+T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses

(2010) Stephanie Gras et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Experience and lessons from surveillance and studies of the 2009 pandemic in Europe

(2010) A. Nicoll et al.   PUBLIC HEALTH

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period

(2010) Caterina Rizzo et al.   VACCINE

In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses

(2009) Yasushi Itoh et al.   NATURE

Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

(2009) Kathy Hancock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

(2008) Xiaocong Yu et al.   NATURE